Web1 Apr 2016 · UKMEC April 2016 Summary Sheet (Amended September 2024) Published on: 1 April 2016. File size: 354kb PDF. File type: Current Clinical Guidance. Download and save … Web2 Nov 2011 · (UKMEC category 4).[4] Both WHOMEC and UKMEC guidance have been reviewed within the past year. WHOMEC 2009 continues to advise a MEC category 2 (benefits outweigh the theoretical or proven risks) for combined hormonal contraceptive (CHC) in women with BMI > or = 30 kg/m2. [3] In adapting MEC for UK practice,
Combined Hormonal Contraception CPD for General Practitioners
Webwomen with severe hypertension (systolic pressure ≥160 mmHg or diastolic pressure ≥100 mmHg) should not use CHC (UKMEC 4) women with less severe hypertension (systolic pressure 140–159 mmHg or diastolic pressure 90–99 mmHg), or with adequately controlled hypertension should not use CHC (UKMEC 3) WebSummary points from FSRH guidance state (2): ... DMPA moves from UKMEC Category 1 to Category 2 - women of all ages using DMPA should be reviewed every 2 years to assess the benefits and risks of use. ... CHC may help to maintain BMD compared with non-use of hormones in the perimenopause; meta-analyses have found a slight increased risk of ... chehalis jewelry store
FSRH UKMEC update (risks of various contraceptive use)
Webprogestogen-only injectables (depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN)) and CHC are classed as UKMEC 3. It is important to … Webare each UKMEC 2 for use of combined hormonal contraception (CHC), these should not be added to make a UKMEC 4, thereby excluding that option. 4 ... (Note- if link not accessible, refer to local copy of the UKMEC Summary Table (Sept 2024)) Drug interactions with hormonal contraception : WebUKMEC Category Definition of category; 1: A condition for which there is no restriction for the use of the method: 2: A condition where the advantages of using the method generally … flemish open science board